期刊文献+

BEAC预处理自体造血干细胞移植治疗淋巴瘤的疗效观察 被引量:2

下载PDF
导出
摘要 0引言 恶性淋巴瘤(ML)是淋巴系统常见的恶性肿瘤,对放化疗敏感,常规治疗可使60%的霍奇金病(Hodgkin’s disease,HD)和30%~50%的非霍奇金淋巴瘤(non-Hodgkin’s disease,NHL)患者得到治愈或长期无病生存,但对恶性度高、耐药及难治的ML疗效差。有研究显示,初治侵袭性淋巴瘤,
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第11期1324-1325,1340,共3页 Cancer Research on Prevention and Treatment
  • 相关文献

参考文献4

二级参考文献34

  • 1张东华,张路,肖毅,黄伟,李登举,冉丹,黄亮,周剑锋,黄梅,孙汉英,刘文励.Clinical Observation of Patients with Hematologic Malignancies Treated with Hematopoietic Stem Cell Transplantation[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2004,24(4):345-349. 被引量:5
  • 2崔秀珍,刘玉忠,杨兴纲,李丽庆,任宝柱.马法兰联合全身照射的自体骨髓移植治疗恶性淋巴瘤[J].中华血液学杂志,1996,17(10):521-523. 被引量:5
  • 3Kurnick NB, Montano A, Gerdes JC, et al. Preliminary observations on the treatment of postirradiation hematopoietic depression in man by the infusion of stored autologous bone marrow [J]. Ann Intern Med, 1958,49:973-986. 被引量:1
  • 4Appelbaum FR, Herzig GP, Ziegler JL, et al. Successful engraftment of cryopreserved autologous bone marrow in patient with malignant lymphoma [ J ]. Blood, 1978,52 : 85-95. 被引量:1
  • 5Apperley J, Carreras E, Gluekman E, et al. Haematopoietie stem cell transplantation (2008 revised edition) [M]. Forum Service Editore, Genoa, 2008. 被引量:1
  • 6张伯龙,高春纪.2006年有关自体造血干细胞移植治疗恶性肿瘤的新信息[M]//中国癌症基金会《中国肿瘤临床年鉴》编辑委员会主编.中国肿瘤临床年鉴.北京:中国协和医科大学出版社,2007:50-75. 被引量:1
  • 7Gulati SC, Shank B, Black P, et al. Autologous bone marrow transplantation for patients with poor-prognosis lymphoma [J]. J Clin Oncol, 1988,6: 1303-1313. 被引量:1
  • 8Haioun C, Lepage E, Gisselbrecht C, et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non- Hodgkin lymphoma in first complete remission: A study of 464 patients. Groupe d'Etude des Lymphomes de l'Aduhe [J]. J Clin Oneol, 1994,12:2543-2551. 被引量:1
  • 9Verdonck LF, van Putten WL, Hagenbeek A, et al. Comparison of CHOP chemotherapy with autologous bone marrow transplantalion for slowly responding patients with aggressive non-Hodgkin's lymphoma [J]. N Engl J Med, 1995, 332: 1045-1051. 被引量:1
  • 10Haioun C,Lepage E, Gisselbreeht C, et al. Benifit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2. Groupe d'Etude des lymphomes de l'Adulte [J]. J Clin Oncol, 1997,15:1131- 1137. 被引量:1

共引文献29

同被引文献12

  • 1孙燕,石远凯.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2011:135-146. 被引量:21
  • 2Greb A,Bohlius J, Trelle S, et al. High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma-results of a comprehensive meta-analy- sis[J]. Cancer Treat Rev, 2007,33 (4) : 338-346. 被引量:1
  • 3Monjanel H,Deconinck E, Perrodeau E, et al. Long-term follow up of tandem high-dose therapy with autoIogous stem cell sup- port for adults with high risk ageadjusted international prognos- tic index aggressive non-Hodgkin Lymphomas: a GOELAMS pi- lot study[J]. Biol Blood Marrow Transplant, 2011,17 (6) : 935- 940. 被引量:1
  • 4Eisenhauer EA, Therasse P, Bogaerts J, et al. New response eval uation criteria in solid tumours: revised RECIST guideline (ver- sion 1.1)[J]. Eur J Cancer,2009,45(2) :228-247. 被引量:1
  • 5Jantunen E, Kuittinen T, Nousiainen T. BEAC or BEAM for high- dose therapy in patients with non-Hodgkin s lymphoma? A single centre analysis on toxicity and efficacy[J]. Leuk Lymphoma,2003,44 (7) : 1151-1158. 被引量:1
  • 6Jo JC,Kang BW,Jang G,et al. BEAC or BEAM high-dose chem- otherapy followed by autologous stem cell transplantation in non- Hodgkins lymphoma patients: comparative analysis of efficacy and toxicity[J]. Ann Hematol,2008,87(1).-43 48. 被引量:1
  • 7Copelan EA. Hematopoietic stem-cell transplantation[J]. N Engl J Med,2006,354(17) :1813-1826. 被引量:1
  • 8Wang J, Zhan P, Ouyang J, et al. Standard chemotherapy is supe- rior to high-dose chemotherapy with autologous stem cell trans plantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis[J]. Med Oncol,2011,28(3) :822-828. 被引量:1
  • 9Mounier N, Canals C, Gisselbrecht C, et al. High-dose and autologous fuse large B cell lymphoma in the rituximab era lapse An therapy for dif- based on data from the european blood and marrow transplanta tion registry[J]. Biol Blood Marrow Transplant, 2012,18 (5) 788-793. 被引量:1
  • 10d Amore F, Relander T, Lauritzsen GF, et al. Up-front autolo- gous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01[J]. J Clin Oncol,2012,30(25):3093-3099. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部